Neogen Corporation Current Federal Tax Expense (Benefit)
Neogen Corporation (NEOG) reported Current Federal Tax Expense (Benefit) of $1.00 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2026-07-30
- Neogen Corporation current federal tax expense (benefit) for fiscal 2026 was $1.00M.
- Neogen Corporation current federal tax expense (benefit) for fiscal 2025 was -$600.00K, a 108.82% decline from fiscal 2024.
- Neogen Corporation current federal tax expense (benefit) for fiscal 2024 was $6.80M, a 21.60% decline from fiscal 2023.
- Neogen Corporation current federal tax expense (benefit) for fiscal 2023 was $8.67M, a 1.11% increase from fiscal 2022.
| Period end | Current Federal Tax Expense (Benefit) 12 month | Current Federal Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2026-05-31 | $1.00M 10-K · filed 2026-07-30 | |
| 2025-05-31 | -$600.00K 10-K · filed 2026-07-30 | -$638.00K 10-K · filed 2025-07-30 |
| 2024-05-31 | $6.80M 10-K · filed 2026-07-30 | |
| 2023-05-31 | $8.67M 10-K · filed 2025-07-30 | |
| 2022-05-31 | $8.58M 10-K · filed 2024-07-30 | |
| 2021-05-31 | $6.98M 10-K · filed 2023-08-15 | |
| 2020-05-31 | $6.89M 10-K · filed 2022-07-27 | |
| 2019-05-31 | $7.17M 10-K · filed 2021-07-30 | $8.45M 10-K · filed 2019-07-30 |
| 2018-05-31 | $9.71M 10-K · filed 2020-07-30 | $10.13M 10-K · filed 2018-07-27 |
| 2017-05-31 | $20.26M 10-K · filed 2019-07-30 | |
| 2016-05-31 | $14.63M 10-K · filed 2018-07-27 | |
| 2015-05-31 | $15.27M 10-K · filed 2017-07-28 | |
| 2014-05-31 | $14.44M 10-K · filed 2016-07-29 | |
| 2013-05-31 | $12.96M 10-K · filed 2015-07-30 | |
| 2012-05-31 | $9.52M 10-K · filed 2014-07-30 | |
| 2011-05-31 | $9.34M 10-K · filed 2013-07-30 | |
| 2010-05-31 | $9.55M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |